[Fukuoka, Japan] [3/16/2025] Chiral Inc., provider of the digital drug discovery platform 'Chiral BPaaS,' has announced that it has won the top prize at the Global Expansion Pitch Event hosted by Fukuoka City. This prestigious award underscores Chiral Inc.'s innovative approach and its potential to make a significant impact on the pharmaceutical industry.
Fukuoka City's Global Expansion Pitch Event focuses on showcasing companies with groundbreaking solutions and strong potential for global impact. In its presentation, Chiral Inc. highlighted how its digital drug discovery platform 'Chiral BPaaS' significantly reduces time and costs in drug discovery, enabling more efficient pharmaceutical development.
Chiral Inc. CEO Wan Qin stated, 'We are honored to receive this recognition from Fukuoka City. This award is a testament to the cutting-edge solutions provided by our digital drug discovery platform 'Chiral BPaaS,' which accelerates the research and development efforts of our pharmaceutical partners.'
Building on this momentum, Chiral Inc. will host an exclusive event for pharmaceutical professionals in Tokyo on March 27th. This event offers unique opportunities such as:
We look forward to connecting with pharmaceutical partners in Tokyo and sharing how Chiral Inc.'s AI drug discovery platform 'Chiral BPaaS' can contribute to their success. This event will serve as a platform for meaningful dialogue and collaboration," added CEO Wan Qin.
Chiral Inc. provides backend functionality as SaaS for software in life sciences and drug discovery fields, which require extensive computational processing, enabling easy cloud computing.
Address：2-6-11 Daimyo, Chuo-ku, Fukuoka City, Fukuoka Prefecture, Fukuoka Growth Next
CEO：Wan Qin
Established：May 2021
Website：https://www.chiral.one
Chiral Inc.
Public Relations: Koji Umeda
TEL: +81-50-5539-4886
E-Mail: info@chiral.one
